9 Stocks With Better-Than-Expected Earnings
According to FactSet, while around 75% of S&P 500 companies typically beat EPS estimates, only around 60% top revenue expectations.
Werewolf Therapeutics Inc. (HOWL)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 2,387,744 | $859,349 | -65% | 0.01% |
| 2. | Balyasny Asset Management Dmitry Balyasny | 1,790,089 | $644,253 | 0% | |
| 3. | Renaissance Technologies Jim Simons | 674,632 | $242,800 | +31% | 0% |
| 4. | Lynx1 Capital Management Weston Nichols | 657,786 | $236,737 | 0.03% | |
| 5. | Sphera Global Healthcare Fund Doron Breen And Mori Arkin | 626,810 | $225,589 | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.98 | 162,539 | $159,288.22 | 6,237,482 | 2025-05-14 | Filing | |
| $0.98 | 52,974 | $51,914.52 | 6,074,943 | 2025-05-13 | Filing | |
| $0.86 | 320,913 | $275,985.18 | 6,021,969 | 2025-05-12 | Filing | |
| $2.21 | 1,853,000 | $4,095,130.00 | 5,701,056 | 2023-01-06 | Filing | |
| $13.37 | 9,285 | $124,140.45 | 4,291,881 | 2021-06-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.31 | 107,429 | $33,302.99 | 0 | 2026-07-07 | Filing | |
| $0.32 | 35,770 | $11,446.40 | 107,429 | 2026-07-06 | Filing | |
| $0.30 | 157,084 | $47,125.20 | 143,199 | 2026-06-29 | Filing | |
| $0.35 | 27,695 | $9,693.25 | 303,719 | 2026-06-17 | Filing | |
| $0.35 | 389,216 | $136,225.60 | 4,268,448 | 2026-06-17 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,217,976 | $438,471 | 0% | |
| 2. | 589,102 | $212,018 | 16.92% | |
| 3. | 335,815 | $120,895 | 0% | |
| 4. | 311,502 | $111,829 | 0% | |
| 5. | 271,478 | $97,705 | 0% |
News See All
Werewolf Therapeutics (HOWL) Eyes 2026 Catalysts Following FDA Guidance and Encouraging INDUKINE Results
On December 18, 2025, Werewolf Therapeutics, Inc.
10 Stocks Under $1 That Will Explode
U.S. equity markets are beginning their 2026 journey without taking a major break from existing trends, according to Morgan Stanley CIO and chief U.S.
Hedge Fund and Insider Trading News: Boaz Weinstein, Greenlight Capital, Bridgewater Associates, Trian Fund Management, Three Arrows Capital, LHG Capital Management, Fate Therapeutics Inc (FATE), Werewolf Therapeutics, Inc. (HOWL), and More
Hedge fund manager Boaz Weinstein doesn't believe Credit Suisse will default on its debt but if it does, the derivatives trade he has on the bank may win big, highlighting just how hedge funds use volatile...
Hedge Fund Resource Center